Dr. Andy Hemmert serves as the Senior Vice President of Molecular Research and Development at bioMérieux, where he leads global teams dedicated to advancing rapid, easy-to-use, and comprehensive molecular diagnostics. Based in Salt Lake City, Utah, Dr. Hemmert oversees innovation across a broad spectrum of infectious disease and antimicrobial resistance diagnostics.

Under his leadership, bioMérieux has developed the industry’s most extensive molecular diagnostic menu for hospital settings, covering respiratory, bloodstream, gastrointestinal, central nervous system, and skeletal infections. He also spearheaded the development of the bioMérieux SpotFire® system, which delivers rapid and actionable results at the point of care.

Dr. Hemmert is a recognized contributor to the scientific community, with numerous publications, patents, and successful research grants to his name. His work continues to shape the future of molecular diagnostics, improving patient outcomes and supporting antimicrobial stewardship worldwide.